SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-027319
Filing Date
2017-11-22
Accepted
2017-11-22 17:02:31
Documents
1
Period of Report
2017-09-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3868
  Complete submission text file 0000899243-17-027319.txt   5441
Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Issuer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address CAY HOUSE, EP TAYLOR DRIVE LYFORD CAY NEW PROVIDENCE C5 N7776
Business Address CAY HOUSE, EP TAYLOR DRIVE LYFORD CAY NEW PROVIDENCE C5 N7776 407-909-9970
Tuesday Thirteen Inc. (Reporting) CIK: 0001723227 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35921 | Film No.: 171220536